Design, Synthesis and Anticancer Screening of Novel Piperidine ydroxamate as HDAC Inhibitors.

Shanmugarajan, R S (2012) Design, Synthesis and Anticancer Screening of Novel Piperidine ydroxamate as HDAC Inhibitors. Masters thesis, KMCH College of Pharmacy, Coimbatore.

[img]
Preview
Text
2602114shanmugarajanrs.pdf

Download (3MB) | Preview

Abstract

Thirteen compounds were synthesized with piperidine in linker region and hydroxamate as Zinc Binding Group (ZBG). They were screened against (HeLa) human cervical cancer cell-line. Of those, compound 3l (N-hydroxy-1-{[(2E)-2-(2-hydroxybenzylidene) hydrazinyl] carbonothioyl} piperidine-4-carboxamide) was found a lead compound with promising IC50 value of 5.83nM. Further the lead compound would be evaluated against a panel of cancer cell lines and establish its possible mechanism through enzyme inhibition assay.

Item Type: Thesis (Masters)
Uncontrolled Keywords: Synthesis; Anticancer Screening; Novel Piperidine ydroxamate; HDAC Inhibitors
Subjects: PHARMACY > Pharmaceutical Chemistry
Depositing User: Ravindran C
Date Deposited: 17 Aug 2017 07:24
Last Modified: 12 Oct 2017 03:00
URI: http://repository-tnmgrmu.ac.in/id/eprint/2665

Actions (login required)

View Item View Item